Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan
Respirology · 2024-06 · 29 (6) · 455-457
DOI: 10.1111/resp.14729 ↗At a glance
Leserbrief in Respirology, published online on 2024-04-23. Written by Keiko Kan-O. Institution: Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan. Major MEDLINE topics: Asthma, Biological Products. Cited 5 times so far (Crossref); 7 references.
Abstract (original language)
with higher asthma-related death rates, we observed that the number of patients with prescribed biologics per 100,000 population tended to be lower.Given that both biologic prescriptions and asthma-related deaths are prevalent among older adults, rectifying specialist imbalances and addressing regional disparities in severe asthma management might be crucial for achieving the 'zero death from asthma strategy'.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
ORCID profiles: Keiko Kan-O
Cite
APA
Kan-O, K. (2024). Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan. Respirology, 29(6), 455-457. https://doi.org/10.1111/resp.14729
Vancouver
Kan-O K. Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan. Respirology. 2024;29(6):455-457. doi:10.1111/resp.14729
BibTeX
@article{KanO2024,
author = {Kan-O, Keiko},
title = {Asthma‐related death trends and biologics use for severe asthma in the super‐aged society of Japan},
journal = {Respirology},
year = {2024},
volume = {29},
number = {6},
pages = {455--457},
doi = {10.1111/resp.14729}
}
EUVIMED